HD
43
8
HBAN
47
7
KEY
24
2
FOXA
67
5
LEG
16
2
HAL
40
11
LNC
28
3
LUV
45
3
STZ
42
2
MET
58
2
AAP
26
5
CNX
67
4
CMS
57
2
NKE
36
2
ABT
54
4
APH
53
3
KHC
11
2
ROP
44
6
CMI
49
2
JPM
59
6
HD
43
8
HBAN
47
7
KEY
24
2
FOXA
67
5
LEG
16
2
HAL
40
11
LNC
28
3
LUV
45
3
STZ
42
2
MET
58
2
AAP
26
5
CNX
67
4
CMS
57
2
NKE
36
2
ABT
54
4
APH
53
3
KHC
11
2
ROP
44
6
CMI
49
2
JPM
59
6
Financhill
Back

Oramed Pharmaceuticals 10K Form

Sell
33

ORMP
Oramed Pharmaceuticals

Last Price:
$2.38
Seasonality Move:
6.43%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-09 10Q ORMP/Oramed Pharmaceuticals Quarterly
2023-11-09 10Q ORMP/Oramed Pharmaceuticals Quarterly
2023-08-10 10Q ORMP/Oramed Pharmaceuticals Quarterly
2023-05-11 10Q ORMP/Oramed Pharmaceuticals Quarterly
2022-11-10 10Q ORMP/Oramed Pharmaceuticals Quarterly
2022-08-10 10Q ORMP/Oramed Pharmaceuticals Quarterly

Receive ORMP News And Ratings

See the #1 stock for the next 7 days that we like better than ORMP

ORMP Financial Statistics

Sales & Book Value

Annual Sales: $1.3M
Cash Flow: $-7.1M
Price / Cash Flow: 0
Annual Sales: $3.89
Price / Book: 0.61

Profitability

EPS (TTM): 0.11000
Net Income (TTM): $4.5M
Gross Margin: $2.7M
Return on Equity: 0%
Return on Assets: 0%

Oramed Pharmaceuticals Earnings Forecast

Key Oramed Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 15 years for ORMP is 299.78%.
  • The Selling, General & Administrative Expenses for ORMP have been equal to 607.31% of Gross Profit Margin.
  • The Research & Development expenses have been 669.48% of Revenue.
  • The Interest Expense is 36.87% of Operating Income.
  • The Net Earning history of ORMP is 412.31% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 7 years.

Oramed Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: ORMP
CUSIP: 68403P
Website: oramed.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 17
Forward P/E Ratio: 0

ORMP Technical Analysis vs Fundamental Analysis

Sell
33
Oramed Pharmaceuticals (ORMP) is a Sell

Is Oramed Pharmaceuticals a Buy or a Sell?